India’s Sun Pharma to acquire Checkpoint Therapeutics for $355 million
(Reuters) -India’s Sun Pharmaceutical Industries said on Monday it will acquire Checkpoint Therapeutics, a U.S.-based immunotherapy and targeted oncology company, for $355 million. The deal is in line with Sun Pharma’s active push in recent years to expand its oncology and immunotherapy portfolio through several acquisitions and collaborations. Last year, it signed a licensing agreement …
India’s Sun Pharma to acquire Checkpoint Therapeutics for $355 million Read More »










